Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Melanoma

Free Subscription 11.05.2026 2 Am J Ophthalmol 2 Br J Dermatol 1 Clin Cancer Res 1 J Am Acad Dermatol 1 J Clin Oncol 1 Melanoma Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Ophthalmol

1. YADAV R, Yadav V, Rastogi S
   Comment on "Interferon Alpha-2a as Treatment for Primary Acquired Melanosis With Atypia and for Primary Acquired Melanosis With Atypia Surrounding Conjunctival Melanoma".
   Am J Ophthalmol. 2026 May 2:S0002-9394(26)00225.
   PubMed        
   
   
2. SAKATA R, Shijo T, Ueno Y, Oda M, et al
   Deep learning-based diagnostic model for ocular surface neoplastic diseases.
   Am J Ophthalmol. 2026 Feb 24:S0002-9394(26)00089.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

3. MARJANOVIC M, Claeson M
   Type 2 diabetes in melanoma patients: a potential prognostic risk factor?
   Br J Dermatol. 2026 May 7:ljag173. doi: 10.1093.
   PubMed        
   
   
4. SAND C, Jayasinghe D, Wolfe R, Mar V, et al
   Evaluating COVID-19 Pandemic Impact on Melanoma Incidence and factors in Regions with Different Infection Control Strategies.
   Br J Dermatol. 2026 May 4:ljag172. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

5. PAKVISAL N, Wongkongkathep P, Bunrasmee W, Sodsai P, et al
   The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma.
   Clin Cancer Res. 2026 May 7. doi: 10.1158/1078-0432.CCR-25-4271.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

6. KITRELL BM, Taylor MA, Kumar EA, Lorenz M, et al
   Rural-Urban Disparities in Melanoma Management: A SEER Database Analysis of Wide Local Excision vs. Mohs Surgery Utilization and Disease-Specific Outcomes.
   J Am Acad Dermatol. 2026 Apr 29:S0190-9622(26)02565.
   PubMed        
   
   

   
   J Clin Oncol

7. VIEITO M, Fontana E, Han CH, Castanon E, et al
   Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600-Mutant Solid Tumors.
   J Clin Oncol. 2026;44:1337-1348.
   PubMed         Abstract available
   
   

   
   Melanoma Res

8. AZENKOT T, Nikanjam M, Mhatre S, Mullen JT, et al
   High dose interleukin-2 in combination with anti-programmed cell death protein 1 to overcome immune checkpoint inhibitor resistance in metastatic melanoma and renal cell carcinoma.
   Melanoma Res. 2026 Apr 30. doi: 10.1097/CMR.0000000000001102.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum